WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
- PMLiVE
Source: pmlive.com
Stay updated with breaking news from Published March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RINVOQ (upadacitinib) is now approved by the European Commission for the treatment of adult patients with moderately to severely active ulcerative colitis who...
Read the latest stories and columns from staff writer Jeffrey Scott Shapiro in The Washington Times.
/PRNewswire/ -- Olympus, a global leader in designing and delivering innovative medical technology solutions, announced its support for the Centers for...
HbA1c is associated with risk for stroke in a dose-dependent manner among patients with diabetes and comorbid atrial fibrillation.